Search Within

Michael David Offin

  1. "Human Oncology and Pathogenesis Program"
Formats
  1. Journal Article (41)
  2. Meeting Abstract (40)
  3. Editorial (2)
  4. Review (1)
Groups
  1. Department of Medicine (84)
  2. GSK Faculty (84)
  3. Human Oncology and Pathogenesis Program (84)
  4. Solid Tumor Oncology Division (84)
  5. Thoracic Oncology (84)
  6. Weinberg Fellows (84)

More Groups

People
  1. Marc Ladanyi (57)
  2. Charles Rudin (45)
  3. Mark Kris (36)
  4. Alexander Drilon (34)
  5. Maria Arcila (31)
  6. Bob Li (28)

More People

Years
  1. 2025 (2)
  2. 2024 (9)
  3. 2023 (5)
  4. 2022 (11)
  5. 2021 (20)
  6. 2020 (9)

More Years

Publications
  1. Journal of Thoracic Oncology (17)
  2. Journal of Clinical Oncology (12)
  3. Clinical Cancer Research (10)
  4. Modern Pathology (7)
  5. JCO Precision Oncology (6)
  6. Cancer Research (4)

More Publications

Publishers
  1. Elsevier Inc. (19)
  2. American Society of Clinical Oncology (18)
  3. American Association for Cancer Research (17)
  4. Nature Research (7)
  5. Oxford University Press (7)
  6. Nature Publishing Group (6)

More Publishers

Results (84)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Molecular characteristics, immunophenotype, and immune checkpoint inhibitor response in BRAF non-V600 mutant lung cancers
    Meeting Abstract

    Offin, M.; Pak, T.; Mondaca, S.; Montecalvo, J.; Rekhtman, N.; Halpenny, D.; Wu, S.; Kris, M.; Paik, P.; Riely, G.; more...
    Journal of Thoracic Oncology (2019)

    Fulltext@MSK | Save
  • Tissue-based molecular and histologic landscape of acquired resistance to osimertinib in patients with EGFR-mutant lung cancers
    Meeting Abstract

    Schoenfeld, A.; Chan, J.; Rizvi, H.; Somwar, R.; Kubota, D.; Daneshbod, Y.; Chang, J.; Offin, M.; Arcila, M.; Pe'Er, D.; more...
    Journal of Thoracic Oncology (2019)

    Fulltext@MSK | Save
  • A clinical utility study of plasma DNA next generation sequencing guided treatment of uncommon drivers in advanced non-small-cell lung cancers
    Meeting Abstract

    Tu, H.; Xu, C.; Tong-Li, C.; Offin, M.; Razavi, P.; Schapira, E.; Namakydoust, A.; Lee, A.; Pavlakis, N.; Clarke, S.; more...
    Journal of Thoracic Oncology (2019)

    Fulltext@MSK | Save
  • Generation and characterization of novel preclinical disease models of NSCLC with NRG1 rearrangements to improve therapy
    Meeting Abstract

    Gladstone, E.; Vojnic, M.; Offin, M.; Delasos, L.; Lui, A.; Siau, E.; Sato, H.; Benayed, R.; Kurth, R.; Mattar, M.; more...
    Journal of Thoracic Oncology (2019)

    Fulltext@MSK | Save
  • Lessons learned from routine, targeted assessment of liquid biopsies for EGFR T790M resistance mutation in patients with EGFR mutant lung cancers
    Journal Article

    Mondaca, S.; Offin, M.; Borsu, L.; Myers, M.; Josyula, S.; Makhnin, A.; Shen, R.; Riely, G. J.; Rudin, C. M.; Ladanyi, M.; more...
    Acta Oncologica (2019)

    Fulltext@MSK | Save
  • Ado-trastuzumab emtansine in patients with HER2 amplified salivary gland cancers (SGCs): Results from a phase II basket trial
    Meeting Abstract

    Li, B. T.; Shen, R.; Offin, M.; Buonocore, D. J.; Myers, M. L.; Venkatesh, A.; Razavi, P.; Ginsberg, M. S.; Ulaner, G. A.; Solit, D. B.; more...
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • Tumor volumetric correlation with plasma cell free DNA (cfDNA) mutation detection in metastatic lung cancers
    Meeting Abstract

    Haseltine, J.; Offin, M.; Myers, M. L.; Makhnin, A.; Adamski, A.; Li, H.; Li, M.; Shaffer, T.; Henderson, S.; Shen, R.; more...
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • MET inhibitor resistance in patients with MET exon 14-altered lung cancers
    Meeting Abstract

    Guo, R.; Offin, M.; Brannon, A. R.; Chow, A.; Delasos, L.; Somwar, R.; Wilkins, O.; Scott, K.; Tian, Y.; Cecchi, F.; more...
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • Concurrent RB1 and TP53 alterations define a subset of EGFR-mutant lung cancers at risk for histologic transformation and inferior clinical outcomes
    Journal Article

    Offin, M.; Chan, J. M.; Tenet, M.; Rizvi, H. A.; Shen, R.; Riely, G. J.; Rekhtman, N.; Daneshbod, Y.; Quintanal-Villalonga, A.; Penson, A.; more...
    Journal of Thoracic Oncology (2019)

    Fulltext@MSK | Save
  • High yield of RNA sequencing for targetable kinase fusions in lung adenocarcinomas with no mitogenic driver alteration detected by DNA sequencing and low tumor mutation burden
    Journal Article

    Benayed, R.; Offin, M.; Mullaney, K.; Sukhadia, P.; Rios, K.; Desmeules, P.; Ptashkin, R.; Won, H.; Chang, J.; Halpenny, D.; more...
    Clinical Cancer Research (2019)

    Fulltext@MSK | Save